The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CONSENT: Randomized controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials.
 
Abhijit Pal
No Relationships to Disclose
 
Robert Daly
No Relationships to Disclose
 
Sarah Stapleton
No Relationships to Disclose
 
Christina Yap
Honoraria - Bayer
Consulting or Advisory Role - Faron Pharmaceuticals
Travel, Accommodations, Expenses - Faron Pharmaceuticals
 
Martin Hong
No Relationships to Disclose
 
Rafael Grochot
No Relationships to Disclose
 
Shybi MohamedKhan
No Relationships to Disclose
 
Julia Elizabeth Lai-Kwon
No Relationships to Disclose
 
Dimitrios Magkos
No Relationships to Disclose
 
Bindumalini Rao Baikady
No Relationships to Disclose
 
Anna Rachel Minchom
Honoraria - Bayer; Chugai Pharma; GlaxoSmithKline; Janssen; Merck; Novartis Pharmaceuticals UK Ltd.
Consulting or Advisory Role - Genmab; Janssen Oncology; Merck; Takeda
 
Udai Banerji
Employment - Institute of Cancer Research
Consulting or Advisory Role - Boehringer Ingelheim; Janssen; Pegascy
Research Funding - AstraZeneca (Inst); BTG (Inst); Carrick Therapeutics (Inst); Chugai Pharma (Inst); Onyx (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - Bayer; Sierra Oncology
 
Johann S. De Bono
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; ImCheck therapeutics; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Pfizer; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; ImCheck therapeutics; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Sanofi Aventis GmbH
Speakers' Bureau - AstraZeneca
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); CellCentric (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Harpoon (Inst); Janssen (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Sanofi (Inst); Sanofi Aventis GmbH (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); CHK1 inhibitor (Inst); PARP inhibitors and DNA repair defects (Inst); Targeting of IL23 in prostate cancer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Bayer; Cellcentric; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Merck Serono; Merck Sharp & Dohme; Pfizer; Sanofi
 
Deme John Karikios
Honoraria - MSD; MSD
Travel, Accommodations, Expenses - Roche
 
Frances M. Boyle
Honoraria - Eisai; Gilead Sciences; Lilly; Roche
Consulting or Advisory Role - Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Expert Testimony - Gilead Sciences; Lilly
Travel, Accommodations, Expenses - Novartis
Other Relationship - Clinical Oncology Society of Australia (COSA); Pamgene; Paxman
(OPTIONAL) Uncompensated Relationships - Paxman; Paxman
 
Juanita Suzanne Lopez
Consulting or Advisory Role - Basilea; CureTeq; Ellipses Pharma; Genmab; Novartis; Pierre Fabre; Roche/Genentech
Research Funding - Astex Pharmaceuticals (Inst); Basilea (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Basilea; Roche/Genentech